FMS Operating Income

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) · Operating Income

FMS logo

FMS Operating Income

Latest reported€1.89B EUR
FMS TTM Operating Income · EUR (€2.92B → €1.89B)
High-resolution chart · PNG

FMS operating income history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share) Operating Income — Trailing twelve months (TTM) (EUR)
Period endingOperating Income (EUR)
1,892,106,000
1,820,652,000
1,826,825,000
1,676,782,000
1,637,759,000
1,668,358,000
1,532,643,000
1,561,355,000
1,422,659,000
1,354,659,000
1,369,646,000
1,293,934,000
1,441,577,000
1,425,087,000
1,511,755,000
1,608,976,000
1,641,994,000
1,725,705,000
1,852,290,000
1,864,710,000
1,991,829,000
2,223,532,000
2,304,409,000
2,459,197,000
2,422,805,000
2,288,138,000
2,269,558,000
2,266,195,000
2,197,529,000
3,077,371,000
3,037,821,000
2,943,821,000
3,025,680,000
2,207,882,000
2,362,161,000
2,590,521,240
2,579,099,741
2,572,145,061
2,397,597,227
2,255,741,907
2,203,844,922
2,115,159,873
2,104,206,799
2,043,926,559
1,963,571,348
1,883,647,060
1,741,352,122
1,648,152,132
1,596,213,495
1,606,800,376
1,668,535,477
1,601,679,560
1,630,796,158
1,677,579,273
1,669,399,420
1,789,262,396
1,740,154,799
1,627,015,338
1,565,212,129
1,490,408,462
1,459,367,778
1,488,752,201
1,488,969,729
1,420,342,779
1,366,615,636
1,282,938,643
1,265,851,829
1,226,197,371
1,217,434,230
1,192,395,927
1,140,132,610
1,094,340,424
1,072,897,591
1,089,156,954
1,116,046,710
1,078,696,333
1,075,536,852
1,077,591,176
1,005,773,393
981,976,892
904,104,586
809,812,316
778,339,238
689,539,713
664,707,186
642,411,055
633,570,842
637,188,406
634,099,346
619,526,764
613,187,149
628,306,587
627,919,679
639,674,095
684,662,171
433,053,179
442,772,429
466,098,332
446,171,537
683,603,286
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.